triclabendazole

FDA Drug Profile — EGATEN

Drug Details

Generic Name
triclabendazole
Brand Names
EGATEN
Application Number
NDA208711
Sponsor
Novartis Pharmaceuticals Corporation
NDC Codes
1
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
TRICLABENDAZOLE

Indications and Usage

1 INDICATIONS AND USAGE EGATEN ® is indicated for the treatment of fascioliasis in patients 6 years of age and older. EGATEN ® tablet is an anthelmintic indicated for the treatment of fascioliasis in patients 6 years of age and older.